Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-09

Clinical Trial Update: Predicting Clinical Efficacy of Immunotherapy Using Pre-treatment andContinuousMonitoring of PD-L1 TPS/CPS on CTCs, and Immunity Exhaustion Scores

View source ↗

Summary

It evaluates whether PD-L1 TPS/CPS on circulating tumor cells measured before and during treatment can predict responses to cancer immunotherapy, and it also as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Circulating Tumor Cells (CTCs), Immunotherapy | Status: RECRUITING